ALEXANDRIA, Va., June 29 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'RELMABI' in its latest official gazette. The trademark application with the serial number 99374398 was filed on Sep. 4, 2025.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and...
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Teva Pharmaceuticals International GmbH Schluselstrasse 12 Jona CH ...